Platelet poor plasma (PPP) is the liquid part of blood after almost all of the platelets have been spun out. Its most important use is in the laboratory, where it is the required sample for clotting tests such as the PT and aPTT. It is also used to make plasma products for transfusion, and more recently as a by-product in platelet-rich plasma (PRP) and cosmetic treatments.
In haematology, PPP is one of those unglamorous materials that sits behind a great deal of everyday medicine. Below I explain what it is, how it is made, where it is used, and where the evidence is solid versus still developing.
What Is Platelet Poor Plasma?
Whole blood contains red cells, white cells, and platelets suspended in plasma, a straw-colored fluid of water, salts, proteins, and clotting factors. When blood is spun in a centrifuge, the heavier cells sink and the plasma rises to the top.
How much of the platelet layer ends up in the plasma depends on how hard and how long the sample is spun. A gentle spin leaves many platelets in the upper plasma, which can be concentrated into platelet-rich plasma (PRP). A harder, longer spin drives nearly all platelets down, leaving platelet poor plasma. For a side-by-side look at how these components are collected from donors, see our comparison of platelet vs plasma donation.
Crucially, PPP still contains the proteins involved in clotting, including fibrinogen and the coagulation factors. That is exactly why it is so useful.
How PPP Compares With Whole Blood and PRP
| Feature | Whole blood | Platelet-rich plasma (PRP) | Platelet poor plasma (PPP) |
|---|---|---|---|
| Platelet level | Normal: 150–450 × 10^9/L | Concentrated above the blood level | Very low; under 10 × 10^9/L for coagulation testing |
| Clotting factors | Present | Present | Present |
| How it is made | Drawn directly | Gentle centrifugation, then concentration | Harder, longer centrifugation (sometimes spun twice) |
| Main uses | Blood count, transfusion | Orthopedic and cosmetic injections | Clotting tests, plasma products, by-product in PRP kits |
A normal adult platelet count of 150 to 450 × 10^9/L is the reference point. PPP intended for clotting tests should fall far below this, and laboratory guidance sets the target at less than 10 × 10^9/L.
How Platelet Poor Plasma Is Prepared
The preparation steps matter, because leftover platelets can distort test results. A typical laboratory process looks like this:
- Collection: blood is drawn into a light-blue-top tube containing 3.2% sodium citrate. Citrate binds calcium and stops the sample from clotting in the tube.
- Correct fill: the tube must be filled to the line so the blood-to-citrate ratio is about 9 to 1. Underfilled tubes give falsely prolonged clotting times.
- Centrifugation: the tube is spun hard enough and long enough to push nearly all platelets into the cell layer.
- Separation: the top plasma is carefully removed without disturbing the layer of cells just above the red cells.
- Double spinning when needed: for sensitive tests or samples that will be frozen, the plasma is spun a second time to remove remaining platelets.
Automated analyzers can confirm the residual platelet count when a laboratory needs to check its process.
Applications of Platelet Poor Plasma
1. Coagulation Testing
This is the core use. The prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen level, thrombin time, D-dimer, and individual factor assays are all run on PPP. These tests help diagnose coagulation disorders such as hemophilia and liver-related bleeding problems, and they monitor anticoagulant medicines.
2. Lupus Anticoagulant and Heparin Testing
Some tests are especially sensitive to leftover platelets. Platelets carry phospholipids that can neutralize a lupus anticoagulant and release a protein called platelet factor 4 that neutralizes heparin. Double-spun PPP helps avoid false-negative lupus anticoagulant results and inaccurate heparin monitoring. This is part of the wider workup of blood coagulation disorders.
3. Transfusion Plasma Products
Plasma separated from donated blood and frozen, known as fresh frozen plasma, is used to replace clotting factors in patients who are bleeding with multiple factor deficiencies. Cryoprecipitate, a concentrated source of fibrinogen, is prepared from it.
4. By-Product in PRP Preparation
When clinics make PRP, the upper layer of plasma left over is PPP. Some protocols use it to adjust the final volume of PRP or to make a fibrin-based gel.
5. Cosmetic and Wound Uses
In aesthetic medicine, PPP is sometimes heated into a gel and used as a soft-tissue filler, or combined with PRP in skin treatments. It has also been explored in wound care. Evidence for these uses is still limited, and protocols vary widely between clinics.
Common Sample Problems That Affect PPP Results
Most errors in clotting tests happen before the sample reaches the analyzer. These are the issues I see most often when a result does not fit the clinical picture:
- Underfilled tubes: too little blood for the amount of citrate falsely prolongs the PT and aPTT.
- High hematocrit: in patients with a very high red cell level, there is less plasma for the same amount of citrate, so the laboratory may need a tube with adjusted citrate volume.
- Clotted or hemolyzed samples: a difficult blood draw can activate clotting in the tube or break red cells, both of which make results unreliable.
- Delays in processing: some clotting factors lose activity if the sample sits too long before it is spun and tested.
- Heparin contamination: blood drawn through a line flushed with heparin can falsely prolong the aPTT.
If a result is unexpected, repeating the test on a fresh, carefully collected sample is often the most useful next step.
What the Evidence Does and Does Not Show
For coagulation testing and transfusion, PPP is a standardized, well-understood material. Its role there is not in question.
The regenerative and cosmetic uses are different. Claims that PPP reduces inflammation, speeds healing, or improves osteoarthritis rest mainly on small studies and practitioner experience. In my view, patients should treat these as experimental, ask what preparation method is used, and be cautious about paying for repeated courses based on marketing claims.
Key Takeaways
- Platelet poor plasma is plasma with almost all platelets removed, while its clotting proteins remain.
- Its main job is as the sample for clotting tests, where the target platelet level is under 10 × 10^9/L.
- Correct tube filling, centrifugation, and sometimes double spinning are essential for accurate results.
- Cosmetic and regenerative uses exist but are supported by limited evidence. Read more in our platelets guide.
Frequently Asked Questions
What is the difference between PRP and PPP?
Both come from the same spun blood sample. PRP has a higher concentration of platelets than normal blood, while PPP has almost none. Both still contain clotting factors.
Why does my clotting test need a special tube?
Clotting tests need blood that has not clotted in the tube, so the light-blue tube contains citrate to hold calcium. The laboratory then spins the sample into platelet poor plasma before testing.
Is platelet poor plasma safe for cosmetic injections?
When it comes from your own blood and is prepared in sterile conditions, the risk of reaction is low, though bruising and infection are possible with any injection. The bigger question is whether it works, and the evidence for that is still limited.
Can leftover platelets change my test results?
Yes. Residual platelets can shorten some clotting times and mask a lupus anticoagulant or interfere with heparin monitoring. That is why laboratories follow strict centrifugation steps.
